KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Evolent Health (EVH) Accumulated Depreciation & Amortization (2016 - 2026)

Evolent Health has reported Accumulated Depreciation & Amortization over the past 11 years, most recently at $115.9 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 2.13% year-over-year to $115.9 million; the TTM value through Dec 2025 reached $115.9 million, down 2.13%, while the annual FY2025 figure was $115.9 million, 2.13% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $115.9 million at Evolent Health, up from $70.8 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $123.4 million in Q4 2023 and troughed at $15.1 million in Q1 2022.
  • A 5-year average of $58.6 million and a median of $53.4 million in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: soared 103.22% in 2023 and later fell 20.5% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $60.0 million in 2021, then rose by 11.92% to $67.2 million in 2022, then surged by 83.67% to $123.4 million in 2023, then decreased by 4.09% to $118.4 million in 2024, then dropped by 2.13% to $115.9 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for EVH at $115.9 million in Q4 2025, $70.8 million in Q3 2025, and $47.2 million in Q2 2025.